EPIDIOLEX® (cannabidiol) oral solution: Now FDA Approved, Pending Rescheduling
Click here to see Press Release.

Sign up here to receive EPIDIOLEX information and availability updates.

Greenwich Biosciences Is Proud To Recognize International Dravet Syndrome Awareness Day

Jun 22, 2017

On June 23rd, we will join individuals and advocacy organizations across the globe as they participate in events to increase awareness about Dravet syndrome, a rare, severe form of childhood-onset epilepsy. GREENWICH Biosciences is committed to supporting these efforts to increase education and fund research for Dravet syndrome, and is dedicated to partnering with those who are working to positively impact the lives of those affected by this difficult to treat condition. For more information about Dravet syndrome click here 

Recent News